Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial

2021 ◽  
Author(s):  
Mathew Cowan ◽  
Wendy M. Swetzig ◽  
Valery Adorno-Cruz ◽  
Mario J. Pineda ◽  
Nikki L. Neubauer ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Efficacy And Safety ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer ◽  
Platinum Resistant

Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, fallopian tube, and primary peritoneal cancer

2014 ◽  
Vol 133 ◽  
pp. 41
Author(s):  
A. Van Arsdale ◽  
M.H. Einstein ◽  
M.A. Brewer ◽  
P.F. Timmins ◽  
J.D. Wright ◽  
...  
Keyword(s):  
Fallopian Tube ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer ◽  
Platinum Sensitive
Sign in / Sign up

Export Citation Format

Share Document